Key Financial Data Of Reporting Company

Immuno-Biological Laboratories Co., Ltd. - Filing #7723736

Concept As at
2018-03-31
As at
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2016-04-01 to
2017-03-31
As at
2017-03-31
As at
2017-03-31
2016-04-01 to
2017-03-31
As at
2016-03-31
2015-04-01 to
2016-03-31
As at
2016-03-31
2015-04-01 to
2016-03-31
2014-04-01 to
2015-03-31
2014-04-01 to
2015-03-31
As at
2015-03-31
As at
2015-03-31
2013-04-01 to
2014-03-31
As at
2014-03-31
2013-04-01 to
2014-03-31
As at
2014-03-31
Key financial data of reporting company
Business results of reporting company
Net sales
643,359,000 JPY
758,286,000 JPY
653,477,000 JPY
741,525,000 JPY
595,057,000 JPY
717,661,000 JPY
595,437,000 JPY
729,030,000 JPY
547,149,000 JPY
670,428,000 JPY
Ordinary profit (loss)
-48,258,000 JPY
-49,013,000 JPY
-1,131,250,000 JPY
-1,170,355,000 JPY
-29,681,000 JPY
-81,797,000 JPY
-41,247,000 JPY
-139,084,000 JPY
-112,198,000 JPY
-99,758,000 JPY
Profit (loss)
-63,920,000 JPY
-2,109,157,000 JPY
-55,321,000 JPY
-110,317,000 JPY
-126,528,000 JPY
Share capital
2,636,302,000 JPY
2,271,815,000 JPY
1,946,344,000 JPY
1,846,099,000 JPY
1,846,099,000 JPY
Total number of issued shares
8,333,090 xbrli:shares
7,419,590 xbrli:shares
6,752,590 xbrli:shares
6,547,590 xbrli:shares
6,547,590 xbrli:shares
Net assets
2,007,243,000 JPY
2,017,777,000 JPY
1,341,441,000 JPY
1,342,190,000 JPY
2,786,374,000 JPY
2,801,813,000 JPY
2,658,428,000 JPY
2,619,566,000 JPY
2,794,736,000 JPY
2,763,270,000 JPY
Total assets
3,242,166,000 JPY
3,295,015,000 JPY
3,425,900,000 JPY
3,392,596,000 JPY
3,356,321,000 JPY
3,359,296,000 JPY
3,163,071,000 JPY
3,138,040,000 JPY
3,147,094,000 JPY
3,070,932,000 JPY
Net assets per share
240.37
241.64
180.23
180.33
411.84
414.13
404.93
398.99
422.69
420.88
Dividend paid per share
Interim dividend paid per share
Basic earnings (loss) per share
-8.51
-7.01
-289.54
-287.52
-8.42
-4.86
-16.84
-24.20
-19.85
-17.99
Diluted earnings per share
Equity-to-asset ratio
0.618 xbrli:pure
0.611 xbrli:pure
0.390 xbrli:pure
0.394 xbrli:pure
0.828 xbrli:pure
0.832 xbrli:pure
0.838 xbrli:pure
0.832 xbrli:pure
0.879 xbrli:pure
0.897 xbrli:pure
Rate of return on equity
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Price-earnings ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Payout ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Net cash provided by (used in) operating activities
73,847,000 JPY
-55,886,000 JPY
-16,984,000 JPY
-108,999,000 JPY
12,161,000 JPY
Net cash provided by (used in) investing activities
-6,278,000 JPY
-458,490,000 JPY
-607,709,000 JPY
21,835,000 JPY
-136,903,000 JPY
Net cash provided by (used in) financing activities
-138,300,000 JPY
2,145,528,000 JPY
286,671,000 JPY
163,736,000 JPY
464,540,000 JPY
Cash and cash equivalents
2,450,875,000 JPY
2,522,102,000 JPY
891,915,000 JPY
1,232,210,000 JPY
1,135,786,000 JPY
Number of employees
48 xbrli:pure
57 xbrli:pure
56 xbrli:pure
47 xbrli:pure
54 xbrli:pure
45 xbrli:pure
45 xbrli:pure
55 xbrli:pure
52 xbrli:pure
41 xbrli:pure
Average number of temporary employees
9 xbrli:pure
11 xbrli:pure
11 xbrli:pure
9 xbrli:pure
12 xbrli:pure
10 xbrli:pure
11 xbrli:pure
13 xbrli:pure
11 xbrli:pure
9 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.